3M Developing Nucleic Acid Test Kits with Lumora's BART Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 3M has entered into a joint development and licensing deal for use of Lumora's BART technology in developing nucleic acid test kits, the firms announced today.

Financial and other details of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.